Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules

Thyroid

Volumn 24, Issue 10, 2014, Pages 1479-1487

  Beaudenon Huibregtse, Sylvie ^a   Alexander, Erik K ^b   Guttler, Richard B ^c   Hershman, Jerome M ^d,e   Babu, Varsha ^d   Blevins, Thomas C ^f   Moore, Paul ^g   Andruss, Bernard ^a   Labourier, Emmanuel ^a  

^a ASURAGEN INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c S Monica Thyroid Diagnostic Center   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Texas Diabetes and Endocrinology   (United States)

^g Austin Diagnostic Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; K RAS PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTOMETRY; CYTOPATHOLOGY; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; ONCOGENE; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PROSPECTIVE STUDY; STANDARD; THYROID CANCER; THYROID CARCINOMA; THYROID INCIDENTAL PAPILLARY MICROCARCINOMA; THYROID PAPILLARY CARCINOMA; UNITED STATES; VERY ELDERLY; CLINICAL TRIAL; EVALUATION STUDY; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; MUTATION; NUCLEOTIDE SEQUENCE; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PHENOTYPE; PRACTICE GUIDELINE; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; STANDARDS; THYROID NEOPLASMS; THYROID NODULE; TUMOR VOLUME; WORKFLOW;

BIOPSY, FINE-NEEDLE; DNA MUTATIONAL ANALYSIS; DOUBLE-BLIND METHOD; GENETIC PREDISPOSITION TO DISEASE; GUIDELINE ADHERENCE; HUMANS; MUTATION; ONCOGENES; ORGANIZATIONAL OBJECTIVES; PATHOLOGY, CLINICAL; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; THYROID NODULE; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; UNITED STATES; WORKFLOW;

EID: 84903134215     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0640     Document Type: Article

References (35)

1. Cibas ES, Ali SZ 2009 The Bethesda System For Reporting Thyroid Cytopathology. Am J Clin Pathol 132: 658-665
2. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167-1214
3. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB 2011A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 21: 243-251
4. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nose V, Marqusee E, Larsen PR, Alexander EK 2007 Long-Term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111: 508-516
5. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, Vielh P, DeMay RM, Sidawy MK, Frable WJ 2008 Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36: 425-437
6. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedus L, Vitti P, Nodules AAETFoT 2010 American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules. Endocr Pract 16: S1-43
7. Nikiforov YE 2011 Molecular analysis of thyroid tumors. Mod Pathol 24: S34-43
8. Xing M 2013 Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13: 184-199
9. Ferraz C, Eszlinger M, Paschke R 2011 Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. J Clin Endocrinol Metab 96: 2016-2026
10. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94: 2092-2098
11. Cantara S, Capezzone M, Marchisotta S, Capuano S, Busonero G, Toti P, Di Santo A, Caruso G, Carli AF, Brilli L, Montanaro A, Pacini F 2010 Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology. J Clin Endocrinol Metab 95: 1365-1369
12. Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN 2011 Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples. J Clin Endocrinol Metab 96: 3390-3397
13. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, LiVolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367: 705-715
14. Moses W, Weng J, Sansano I, Peng M, Khanafshar E, Ljung BM, Duh QY, Clark OH, Kebebew E 2010 Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34: 2589-2594
15. Eszlinger M, Krogdahl A, Munz S, Rehfeld C, Precht Jensen EM, Ferraz C, Bosenberg E, Drieschner N, Scholz M, Hegedus L, Paschke R 2014 Impact of molecular screening for point mutations and rearrangements in routine air-dried fine-needle aspiration samples of thyroid nodules. Thyroid 24: 305-313
16. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW 2012 The Bethesda System for Reporting Thyroid Cytopathology: a meta-Analysis. Acta Cytol 56: 333-339
17. Laosinchai-Wolf W, Ye F, Tran V, Yang Z, White R, Bloom K, Choppa P, Labourier E 2011 Sensitive multiplex detection of KRAS codons 12 and 13 mutations in paraffinembedded tissue specimens. J Clin Pathol 64: 30-36
18. Ye F, Laosinchai-Wolf W, Labourier E 2012 An optimized technology platform for the rapid multiplex molecular analysis of genetic alterations associated with leukemia. Cancer Genet 205: 488-500
19. Smith DL, Lamy A, Beaudenon-Huibregtse S, Sesboue R, Laosinchai-Wolf W, Sabourin JC, Labourier E 2014A Multiplex Technology Platform for the Rapid Analysis of Clinically Actionable Genetic Alterations and Validation for BRAF p.V600E Detection in 1549 Cytologic and Histologic Specimens. Arch Pathol Lab Med 138: 371-378
20. Armitage P, Berry G 1994 Statistical Methods in Medical Research. Blackwell Scientific Publications, London
21. Newcombe RG 1998 Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17: 857-872
22. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu CG, Franssila K, Suster S, Kloos RT, Croce CM, de la Chapelle A 2005 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075-19080
23. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ, 3rd, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21: 1139-1146
24. Dettmer M, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN 2013 Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 23: 1383-1389
25. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA 2010 Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23: 1191-1200
26. Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA 2009 Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid 19: 119-127
27. Vivero M, Kraft S, Barletta JA 2013 Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid 23: 273-279
28. Baloch ZW, Livolsi VA 2002 Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 117: 143-150
29. Goffredo P, Cheung K, Roman SA, Sosa JA 2013 Can minimally invasive follicular thyroid cancer be approached as a benign lesion? A population-level analysis of survival among 1, 200 patients. Ann Surg Oncol 20: 767-772
30. Kakudo K, Bai Y, Liu Z, Ozaki T 2012 Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer. Pathol Int 62: 155-160
31. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, DeLellis RA, Harach HR, Kakudo K, LiVolsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28: 1336-1340
32. Caronia LM, Phay JE, Shah MH 2011 Role of BRAF in thyroid oncogenesis. Clin Cancer Res 17: 7511-7517
33. Li C, Lee KC, Schneider EB, Zeiger MA 2012 BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-Analysis. J Clin Endocrinol Metab 97: 4559-4570
34. Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, ONeill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V 2013 Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. JAMA 309: 1493-1501
35. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM 2003 The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56: 1129-1135